Karen Krasney
General Counsel at Capricor Therapeutics, Inc. (CAPR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 29SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 24,10030,547 held (−44%) | $30.38 | $732K | -74.2% |
| Jun 24SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 50030,547 held (−2%) | $30.00 | $15K | -73.9% |
| Jun 24SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 40030,547 held (−1%) | $30.00 | $12K | -73.9% |
| May 4SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 25,00030,547 held (−45%) | $31.70 | $792K | -75.3% |
| Apr 1SEC | CAPRCapricor Therapeutics, Inc. | Sell Plan | 25,00030,547 held (−45%) | $30.12 | $753K | -74.0% |
- Sell
General Counsel Karen Krasney sold $732K of CAPR at $30.38 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Karen Krasney sold $15K of CAPR at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Karen Krasney sold $12K of CAPR at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Karen Krasney sold $792K of CAPR at $31.70 — cuts the stake by 45%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Karen Krasney sold $753K of CAPR at $30.12 — cuts the stake by 45%; pre-scheduled 10b5-1 plan sale.